A system to estimate relapse-free survival probabilities and probable benefit from adjuvant therapy in patients with operable breast cancer.

被引：0
|
作者：
Miles, DW
Ryder, K
Rubens, RD
Royston, P
机构：
[1] Guys Hosp, London SE1 9RT, England
[2] MRC, Clin Trials Unit, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] Paclitaxel adjuvant therapy improves relapse-free survival
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2009, 6 (8) : 437 - 437
  • [2] Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients
    Farmen, Ragne K.
    Nordgard, Oddmund
    Gilje, Bjornar
    Shammas, Fuad V.
    Kvaloy, Jan T.
    Oltedal, Satu
    Heikkilae, Reino
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 251 - 258
  • [3] Clusterin Overexpression and Relapse-free Survival in Breast Cancer
    Yom, Cha Kyong
    Woo, Hee-Yeon
    Min, Sun Young
    Kang, So Young
    Kim, Hee Sung
    ANTICANCER RESEARCH, 2009, 29 (10) : 3909 - 3912
  • [4] Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients
    Ragne K. Farmen
    Oddmund Nordgård
    Bjørnar Gilje
    Fuad V. Shammas
    Jan T. Kvaløy
    Satu Oltedal
    Reino Heikkilä
    Breast Cancer Research and Treatment, 2008, 108 : 251 - 258
  • [5] Inflammatory breast carcinoma signature and relapse-free survival in patients with noninflammatory breast cancer
    Van Laere, S. J.
    Van den Eynden, G. G.
    Van der Auwera, I.
    Trinh, X. B.
    van Dam, P. A.
    Van Marck, E. A.
    Vermeulen, P. B.
    Dirix, L. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] ADJUVANT THERAPY IN OPERABLE BREAST-CANCER - A DEFINITION OF BENEFIT
    GELBER, RD
    GOLDHIRSCH, A
    CONTROLLED CLINICAL TRIALS, 1985, 6 (03): : 226 - 226
  • [7] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY
    LINK, MP
    GOORIN, AM
    MISER, AW
    GREEN, AA
    PRATT, CB
    BELASCO, JB
    PRITCHARD, J
    MALPAS, JS
    BAKER, AR
    KIRKPATRICK, JA
    AYALA, AG
    SHUSTER, JJ
    ABELSON, HT
    SIMONE, JV
    VIETTI, TJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25): : 1600 - 1606
  • [8] PROGESTERONE-RECEPTOR ACTIVITY AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH PRIMARY BREAST-CANCER - THE ROLE OF ADJUVANT CHEMOTHERAPY
    RAEMAEKERS, JMM
    BEEX, LVAM
    PIETERS, GFFM
    SMALS, AGH
    BENRAAD, TJ
    KLOPPENBORG, PWC
    WOBBES, T
    VANDAAL, W
    HOLLAND, R
    HENDRIKS, J
    WAGENER, D
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 9 (03) : 191 - 199
  • [9] The Influence of the BAD Apoptosis Pathway on Breast Cancer Progression and Relapse-Free Survival after Adjuvant Treatment
    Ismail-Khan, R. R.
    Marichion, D. C.
    Xiong, Y.
    Fulp, W. J.
    Kamath, S. G.
    Eschrich, S. A.
    Chen, D-T
    Lancaster, J. M.
    CANCER RESEARCH, 2010, 70
  • [10] Early relapse and predictors of relapse-free survival in neoadjuvant chemotherapy-treated breast cancer patients
    Martin, Natalie
    Pasztorova, Julia
    Hibell, Isabella
    Wheatley, Duncan
    CANCER RESEARCH, 2022, 82 (04)
12345